Fibroblast growth factor-23 and phosphorus metabolism

Endocrine Development

Volumn 21, Issue , 2011, Pages 67-77

  Tiosano, Dov ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE PROTEIN 17; ALKALINE PHOSPHATASE; CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; METALLOPROTEINASE; PHOSPHORUS; UNCLASSIFIED DRUG; VITAMIN D;

ARTERIOSCLEROSIS; ARTICLE; BONE DISEASE; HUMAN; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; INTESTINE ABSORPTION; KIDNEY TUBULE ABSORPTION; NEVUS; NEVUS UNIUS LATERIS; NONHUMAN; OSTEOCYTE; OSTEOGLOPHONIC DYSPLASIA; OSTEOMALACIA; PHENOTYPE; PHOSPHATE EXCRETION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CALCINOSIS; VITAMIN BLOOD LEVEL;

ANIMALS; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; MODELS, BIOLOGICAL; NEOPLASMS; OSTEOCYTES; PHOSPHORUS; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS;

EID: 84926103061     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000328129     Document Type: Article

References (39)

1. Hochberg Z: Abnormalities of Calcium and Parathyroid Hormone. Philadelphia, Lippincott Williams and Wilkins, 2004.
2. Quarles LD: Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 2008;118: 3820-3828.
3. Rizzoli R, Fleisch H, Bonjour JP: Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply. J Clin Invest 1977;60:639-647. (Pubitemid 8180867)
4. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA: Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 2005;146:5358-5364. (Pubitemid 41653049)
5. Murer H, Hernando N, Forster I, Biber J: Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 2000;80:1373-1409.
6. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T: Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-6505. (Pubitemid 32488266)
7. Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK: 1alpha,25-Dihydroxyvitamin D3 upregulates FGF-23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005;289:G1036-G1042. (Pubitemid 41740608)
8. Garringer HJ, Malekpour M, Esteghamat F, Mortazavi SM, Davis SI, Farrow EG, Yu X, Arking DE, Dietz HC, White KE: Molecular genetic and biochemical analyses of FGF-23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 2008;295:E929-E937.
9. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E: Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004;36:579-581. (Pubitemid 38715983)
10. Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ: A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007;117:2684-2691. (Pubitemid 47494368)
11. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T: FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-435. (Pubitemid 38787398)
12. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51. (Pubitemid 27494749)
13. Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR: Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 2007;104:19796-19801.
14. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y: Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem Biophys Res Commun 1998;242:626-630. (Pubitemid 28412578)
15. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG: The beta-glucuronidase Klotho hydrolyzes and activates the TRPV5 channel. Science 2005;310:490-493. (Pubitemid 41507962)
16. Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz-Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M FGF-23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 2010;21:1125-1135.
17. Beck GR Jr: Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 2003;90:234-243. (Pubitemid 37222192)
18. Beck GR Jr, Moran E, Knecht N: Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 2003; 288:288-300. (Pubitemid 36966077)
19. Beck GR Jr, Zerler B, Moran E: Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 2000;97: 8352-8357. (Pubitemid 30639676)
20. Meleti Z, Shapiro IM, Adams CS: Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone 2000;27:359-366. (Pubitemid 30658118)
21. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T: Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest 2004;113:561-568. (Pubitemid 38542505)
22. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B: Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phexdeficient mice. Matrix Biol 2004;23:421-432. (Pubitemid 39576657)
23. Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S: Fibroblast growth factor-23 (FGF-23) in patients with transient hypoparathyroidism: Its important role in serum phosphate regulation. Endocr J 2007;54:465-470. (Pubitemid 47105436)
24. Antoniucci DM, Yamashita T, Portale AA: Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006;91:3144-3149. (Pubitemid 44271770)
25. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB: Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003;64:2272-2279. (Pubitemid 37449564)
26. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD: Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003;278:37419-37426. (Pubitemid 37175262)
27. Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM: DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006;38:1248-1250. (Pubitemid 44646286)
28. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, Schauer G, Lehmann M, Roscioli T, Schnabel D, Epplen JT, Knisely A, Superti-Furga A, McGill J, Filippone M, Sinaiko AR, Vallance H, Hinrichs B, Smith W, Ferre M, Terkeltaub R, Nurnberg P: Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003;34:379-381. (Pubitemid 36935330)
29. Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM: Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 2010;86: 267-272.
30. Bai XY, Miao D, Goltzman D, Karaplis AC: The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 2003;278:9843-9849. (Pubitemid 36800487)
31. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P: FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112:683-692. (Pubitemid 38057709)
32. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H: Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-1663. (Pubitemid 36459471)
33. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R: Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003;112:785-794. (Pubitemid 38057719)
34. Menon PS, Madhavi N, Mukhopadhyaya S, Padhy AK, Bal CS, Sharma LK: Primary hyperparathyroidism in a 14 year old girl presenting with bone deformities. J Paediatr Child Health 1994;30:441-443. (Pubitemid 24304047)
35. Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Y, Reyes-Mugica M, Carpenter TO, Lifton RP: A translocation causing increased alpha-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci U S A 2008;105:3455-3460. (Pubitemid 351723574)
36. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A: Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006;116:2201-2207. (Pubitemid 44162329)
37. White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, Fitzpatrick D, Yu K, Ornitz DM, Econs MJ: Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 2005;76:361-367. (Pubitemid 40129563)
38. Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T: A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 2005; 90:5523-5527. (Pubitemid 41415453)
39. Garringer HJ, Fisher C, Larsson TE, Davis SI, Koller DL, Cullen MJ, Draman MS, Conlon N, Jain A, Fedarko NS, Dasgupta B, White KE: The role of mutant UDP-N-acetyl-alpha-D-galactosaminepolypeptide N- acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab 2006;91:4037-4042. (Pubitemid 44536883)